Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
CALL
Zimmer Biomet
ZBH
$18.4B
| $3.4M | 0.01% |
33,063
+20,806
| +170% | +$2.01M |
|
1452
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
| $3.4M | 0.01% |
141,600
-543,900
| -79% | -$12.6M |
|
1453
H&R Block
HRB
$5.86B
| $3.4M | 0.01% |
130,624
+67,525
| +107% | +$2.12M |
|
1454
CALL
ProShares UltraPro QQQ
TQQQ
$37.4B
| $3.4M | 0.01% |
1,598,400
-1,728,000
| -52% | -$3.21M |
|
1455
PUT
iShares MSCI South Korea ETF
EWY
$25.7B
| $3.4M | 0.01% |
65,300
-154,300
| -70% | -$7.46M |
|
1456
CALL
GSK
GSK
$106B
| $3.4M | 0.01% |
67,920
+6,880
| +11% | +$343K |
|
|
XEC
1457
DELISTED
CIMAREX ENERGY CO
XEC
| $3.39M | 0.01% |
34,939
+8,571
| +33% | +$754K |
|
1458
CALL
Zillow
Z
$7.56B
| $3.38M | 0.01% |
147,100
-58,276
| -28% | -$1.22M |
|
|
S
1459
DELISTED
Sprint Corporation
S
| $3.38M | 0.01% |
1,127,498
+203,999
| +22% | +$652K |
|
1460
PUT
Pacira BioSciences
PCRX
$997M
| $3.38M | 0.01% |
65,000
| – | – |
|
1461
Marvell Technology
MRVL
$196B
| $3.37M | 0.01% |
337,349
+240,385
| +248% | +$2.22M |
|
1462
CALL
Patterson-UTI
PTEN
$3.76B
| $3.37M | 0.01% |
198,300
+144,000
| +265% | +$2.15M |
|
1463
Sabesp
SBS
$18.7B
| $3.37M | 0.01% |
2,897,460
+59,052
| +2% | +$62.4K |
|
|
DST
1464
DELISTED
DST Systems Inc.
DST
| $3.37M | 0.01% |
60,118
+44,480
| +284% | +$2.37M |
|
1465
CALL
Danaher
DHR
$144B
| $3.37M | 0.01% |
53,264
-45,379
| -46% | -$2.71M |
|
1466
Essential Utilities
WTRG
$11.4B
| $3.37M | 0.01% |
108,548
-1,112
| -1% | -$34.4K |
|
1467
Gartner
IT
$11.7B
| $3.36M | 0.01% |
37,781
-8,466
| -18% | -$716K |
|
1468
CALL
CF Industries
CF
$17.3B
| $3.36M | 0.01% |
108,400
-8,400
| -7% | -$274K |
|
|
SHLX
1469
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $3.36M | 0.01% |
93,328
+15,833
| +20% | +$558K |
|
|
TFCFA
1470
PUT
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $3.36M | 0.01% |
124,400
+16,700
| +16% | +$447K |
|
1471
Dover
DOV
$28.4B
| $3.35M | 0.01% |
64,889
+3,835
| +6% | +$186K |
|
|
ATHN
1472
PUT
DELISTED
Athenahealth, Inc.
ATHN
| $3.35M | 0.01% |
24,300
-36,600
| -60% | -$5.02M |
|
1473
iShares MSCI Canada ETF
EWC
$6.46B
| $3.35M | 0.01% |
145,444
-81,386
| -36% | -$1.74M |
|
1474
CALL
T. Rowe Price
TROW
$24.3B
| $3.34M | 0.01% |
45,800
+41,700
| +1,017% | +$2.9M |
|
1475
PUT
Hershey
HSY
$36.6B
| $3.34M | 0.01% |
36,300
-5,100
| -12% | -$455K |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.